26. March 2018
The completed analysis, performed by GlobalData, a data and analytics company, reveals a number of interesting insights. The pharma sector’s 2017 v 2016 year on year performance inevitably created a mixed picture, with only half of the top 25 companies’ market cap achieving double digit growth and five players, Merck US, Celgene, GlaxoSmithKline, Allergan and Shire seeing their market cap fall. However, based on market cap J&J, Roche and Pfizer retained market position among the top...
29. March 2017
ABSTRACT: Control of elemental impurities in pharmaceutical materials is currently undergoing a transition from control based on concentrations in components of drug products to control based on permitted daily exposures in drug products.Within the pharmaceutical community, there is uncertainty regarding the impact of these changes on manufactures of drug products. This uncertainty is fueled in part by a lack of publically available information on elemental impurity levels in common...